Summary
Lymphocytes from patients with HBs-Ag-positive and -negative acute, chronic-persistent, and chronic-active hepatitis, from healthy controls and from patients with alcoholic liver cirrhosis were tested under standardized conditions. These included use of a single charge of Phytohemagglutinin (PHA-P) dissolved and diluted in one operation, of a single pool of homologous serum of the major blood group AB found free of HBs-Ag and cytotoxic factor, and elaboration of PHA dose response curves in the presence of autologous and homologous serum in each case examined. During the early phase of acute virus hepatitis B and non-B, and in HBs-Ag-positive chronic persistent and active hepatitis, hyperresponsiveness of lymphocytes to PHA was observed independently of the source of the serum present in the culture. Lymphocyte responsiveness returned to normal in the later phase of acute hepatitis and was depressed in alcoholic liver cirrhosis and in cases of HBs-Ag-positive chronic active hepatitis in which cirrhosis had developed. Although the cause of these alterations in lymphocyte responsiveness is not completely understood, the central role of a primary change of the lymphocytes themselves affecting their ability to react to PHA seems probable.
Similar content being viewed by others
References
Allison, A. C.: Brit. Med. Bull.23, 60–62 (1967)
Berthold, H.: Dtsch. Ges. Inn. Med.79, 637–639 (1973)
Blumberg, B. S., Sutnick, A. I., London, W. T.: Am. J. Med.48, 1–8 (1970)
Burnet, F. M.: Lancet1968 II, 610–613
Carter, R. L.: J. Clin. Pathol.19, 448–455 (1966)
Dau, P., Kulcsar, G., Sallay, K., Nasz, I.: Blut22, 211–215 (1971)
De Groote, J., Desmet, V., Gedigk, P., Korb, G., Popper, H., Poulsen, H., Scheuer, P. J., Schmid, M., Thaler, H., Uehlinger, E., Wepler, W.: Dtsch. Med. Wschr.93, 2101–2102 (1968)
Doniach, D., Walker, J. G., Roitt, I. M., Berg, P. A.: New Engl. J. Med.282, 86–88 (1970)
Duc, N., Henle, W. J.: J. Bacteriol.92, 258–265 (1966)
Dudley, F. J., Fox, R. A., Sherlock, S.: Lancet1972 I, 723–726
Edgington, T. S., Chisari, F. V.: Am. J. Med. Sci.270, 213–227 (1975)
Elves, M. W., Roath, S., Israels, M. C. G.: Lancet1963 I, 806–807
Fauconnier, M. B.: C.R. Acad. Sc. (Paris)259, 243–245 (1964)
Fireman, P., Friday, G., Kumate, J.: Pediatrics43, 264–272 (1969)
Gurvich, E. B., Svet Molavstaya, I. A.: Nature220, 1050–1051 (1968)
Havemann, K.: Z. Ges. Exp. Med.151, 138–162 (1969)
Horvat, M., Havemann, K., Kallenbrunnen, H., Grünwald, K., Menge, H.: Untersuchungen zur Bestimmung optimaler Markierungsbedingungen. (in press, 1979)
Hughes, D., Caspary, E. A.: Int. Arch. Allergy37, 506–531 (1970)
Kissling, M., Speck, B.: Vox Sang.21, 261–268 (1971)
Klingelhöfer, H. L., Malchow, H., Havemann, K., Börngen, U.: Dtsch. Ges. Inn. Med.78, 884–887 (1972)
Knolle, J., Meyer zum Büschenfelde, K. H., Friedrichs, N., Bolte, J. P.: Dtsch. Ges. Inn. Med.79, 639–641 (1973)
Kössling, F. K., Meyer zum Büschenfelde, K. H.: Virchows Arch. Abt. A, Pathol. Anat.345, 365–376 (1968)
Kössling, F. K., Meyer zum Büschenfelde, K. H.: Z. Ges. Exp. Med.153, 150–161 (1970)
Larsen, J. H.: Dan. Med. Bull.16, 146–154 (1969)
Leevy, C. M., Tamburro, C. H., Sorrell, M. F., Stone, R.: C. M. A. J.106, 435–441 (1972)
Lehner, T., Cameron, J. S., Ward, R. G.: Clin. Exp. Immunol.6, 439–444 (1970)
Mackay, I. R., Weidens, S., Hasker, J.: Ann. N.Y. Acad. Sci.124, 767–780 (1965)
Malacarne, P., Dallapiccola, B.: Infect. Dis.123, 213–215 (1971)
Malchow, H., Horstkamp, B., Johanssen, R., Schmidt, W., Havemann, K.: Verh. Dtsch. Ges. Inn. Med.80, 1623–1627 (1974)
Martini, G. A., Sodomann, C.-P.: Cellular immune reactions in chronic hepatitis. In: Chronic hepatitis, Int. Symp. Montecatini 1975, pp. 100–106. Basel: Karger 1976
Mella, B., Lang, D. J.: Science155, 80–81 (1967)
Miller, G., Enders, J. F.: J. Virol.2, 787–792 (1969)
Miller, J., Smith, M. G. M., Mitchell, C. G., Reed, W. D., Eddleston, A. L. W. F., Williams, R.: Lancet1972 II, 296–297
Millman, I., Agrawal, S. S., Bugbee, S. J., Blumberg, B. S., Loeb, L. A.: Proc. Soc. Exp. Biol. Med.137, 1498–1502 (1971)
Millman, I., Agrawal, S. S., Bugbee, S. J., Blumberg, B. S., Loeb, L. A.: Proc. Soc. Exp. Biol. Med.138, 198–203 (1971)
Montgomery, J. R., South, M. A., Rawls, W. E., Melnick, J. L., Olson, G. B., Dent, P. B., Good, R. A.: Science157, 1068–1070 (1967)
Nahmias, A. J., Kibrick, S., Rosan, R. C.: J. Immunol.93, 69–74 (1964)
Nowell, P. C.: Cancer Res.20, 462–466 (1960)
Oldstone, M. B. A., Dixon, F. J.: J. Exp. Med.131, 1–14 (1970)
Olson, G. B., South, A. M., Good, R. A.: Nature214, 695–699 (1967)
Olson, G. B., Dent, P. B., Rawls, W. E., South, M. A., Montgomery, J. R., Melnick, J. L., Good, R. A.: J. Exp. Med.128, 47–68 (1968)
Oppenheim, J. J.: Fed. Proc.27, 21–28 (1968)
Pesendorfer, F., Krassnitzky, O., Wewalka, F.: Vox Sang.19, 200–204 (1970)
Popper, H., Mackay, I. R.: Lancet1972 I, 1161–1164
Prince, A. M., Hargrove, R. L., Szmuness, W., Cherubin, C. E., Fontana, V. J., Jeffries, G. H.: New Engl. J. Med.282, 987–991 (1970)
Rössler, R., Havemann, K., Dölle, W.: Verh. Dtsch. Ges. Inn. Med.74, 533–537 (1968)
Rössler, R., Havemann, K., Dölle, W.: Klin. Wschr.47, 803–806 (1969)
Rössler, R., Havemann, K.: Dtsch. Med. Wschr.95, 34–39 (1970)
Sample, W. F., Chrestien, P. B.: Clin. Exp. Immunol.9, 419–427 (1971)
Schellekens, P. T. A., Eijsvoogel, V. P.: Clin. Exp. Immunol.3, 571–586 (1968)
Schellekens, P. T. A., Eijsvoogel, V. P.: Clin. Exp. Immunol.7, 229–240 (1970)
Schellekens, P. T. A., Vriesendorp, B., Eijsvoogel, V. P., Leeuwen, A. v., Rood, J. J. v., Miggiano, V., Ceppellini, R.: Clin. Exp. Immunol.7, 241–247 (1970)
Sodomann, C.-P., Malchow, H., Havemann, K.: Internist13, 427–428 (1972)
Sodomann, C.-P., Havemann, K.: Internist14, 583–595 (1973)
Sodomann, C.-P., Rother, M., Havemann, K.: Dtsch. Ges. Inn. Med.80, 1689–1693 (1974)
Sodomann, C.-P.: Leber — Magen — Darm5, 123–131 (1975)
Sodomann, C.-P.: Technik und Signifikanz immunologischer Methoden in der Leberdiagnostik. In: Neues aus der Hepatologie und Gastroenterologie, Bürgel (ed.). Stuttgart: Schattauer 1976
Sodomann, C.-P.: Diagnostik10, 440–444 (1977)
Tobias, H., Safron, A. P., Schaffner, F.: Lancet1967 I, 193–195
Tripodi, D., Lyons, S., Davies, D.: Transplantation11, 487–488 (1971)
Willems, F. T. C., Melnick, J. L., Rawls, W. E.: Proc. Soc. Exp. Biol. Med.130, 652–661 (1969)
Willems, F. T. C., Rawls, W. E.: Arch. Ges. Virusforsch.27, 352–355 (1969)
Winter, G. C. B., McCarthy, C. F., Read, A. E., Yoffey, J. M.: Brit. J. Exp. Pathol.48, 66–80 (1967)
Yeung Laiwah, A. A. C.: Lancet1971 II, 470–471
Author information
Authors and Affiliations
Additional information
Supported by the Deutsche Forschungsgemeinschaft Ha 538/5
Rights and permissions
About this article
Cite this article
Sodomann, C.P., Rother, M., Havemann, K. et al. Lymphocyte proliferation to Phytohemagglutinin (PHA) in hepatitis B antigen-positive and -negative hepatitis. Res. Exp. Med. 175, 95–107 (1979). https://doi.org/10.1007/BF01851238
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01851238